Aurobindo Pharma Limited (NSE: AUROPHARMA)

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 77.96B INR in the quarter ending September 30, 2024, with 7.99% growth. This brings the company's revenue in the last twelve months to 302.95B, up 12.41% year-over-year. In the fiscal year ending March 31, 2024, Aurobindo Pharma had annual revenue of 290.02B with 16.68% growth.

• Revenue (ttm): 302.95B
• Revenue Growth: +12.41%
• P/S Ratio: 2.43
• Revenue / Employee: 11.65M
• Employees: 26,015
• Market Cap: 733.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	290.02B	41.46B	16.68%
Mar 31, 2023	248.55B	14.00B	5.97%
Mar 31, 2022	234.55B	-13.19B	-5.32%
Mar 31, 2021	247.75B	16.76B	7.26%
Mar 31, 2020	230.99B	35.35B	18.07%